Denosumab Demonstrates Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Tri

		HER2 Support Group Forums > Breast Cancer Newsfeed
Denosumab Demonstrates Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Tri

07-08-2009, 04:17 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,915	Denosumab Demonstrates Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Tri Amgen (Nasdaq: AMGN) announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 04:22 AM.